Skip to content Skip to footer
Akili

Akili Interactive Labs

About Akili Interactive Labs website Akili Interactive Labs is a digital therapeutics company with over $300M in funding and went IPO through a SPAC in August of 2022. Akili was awarded FDA clearance EUA (emergency use authorization) for their prescription video game therapeutic EndeavorRx in June of 2020. The software is currently indicated for use…

Read More